Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobumi Miyake

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|June 24, 2016
[Effectiveness of N-acetylcysteine in the treatment of schizophrenia]Nobumi Miyake, Seiya Miyamoto
Cureus|September 11, 2025
Successful Transition From Covert, Involuntary Oral Medication to Consensual, Long-Acting, Injectable Antipsychotic Therapy in a Patient With Schizophrenia: A Case Report From JapanYoshiyo Oguchi, Nobumi Miyake
Neuropsychopharmacology Reports|April 18, 2024
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist surveyYoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Neuropsychopharmacology Reports|January 6, 2024
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative reviewYoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Clinical Schizophrenia & Related Psychoses|September 26, 2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?Nobumi Miyake, Seiya Miyamoto, L Fredrik Jarskog
Psychiatry and Clinical Neurosciences|October 10, 2013
Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive functionShin Ogino, Seiya Miyamoto, Nobumi Miyake, et al.
CNS Neuroscience & Therapeutics|January 5, 2011
Presynaptic dopamine in schizophreniaNobumi Miyake, Judy Thompson, Mette Skinbjerg, et al.
Psychiatry and Clinical Neurosciences|July 1, 2008
Successful treatment of delusional disorder with low-dose aripiprazoleSeiya Miyamoto, Nobumi Miyake, Shin Ogino, et al.
Psychiatry and Clinical Neurosciences|December 18, 2007
Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophreniaSeiya Miyamoto, Nobumi Miyake, Shin Ogino, et al.
Psychopharmacology|August 9, 2020
N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Nobumi Miyake, Makoto Okuya, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|June 24, 2016
[Effectiveness of N-acetylcysteine in the treatment of schizophrenia]Nobumi Miyake, Seiya Miyamoto
Cureus|September 11, 2025
Successful Transition From Covert, Involuntary Oral Medication to Consensual, Long-Acting, Injectable Antipsychotic Therapy in a Patient With Schizophrenia: A Case Report From JapanYoshiyo Oguchi, Nobumi Miyake
Neuropsychopharmacology Reports|April 18, 2024
Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist surveyYoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Neuropsychopharmacology Reports|January 6, 2024
Long-acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID-19 pandemic: A micro-narrative reviewYoshiyo Oguchi, Nobumi Miyake, Kumiko Ando
Clinical Schizophrenia & Related Psychoses|September 26, 2012
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?Nobumi Miyake, Seiya Miyamoto, L Fredrik Jarskog
Psychiatry and Clinical Neurosciences|October 10, 2013
Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive functionShin Ogino, Seiya Miyamoto, Nobumi Miyake, et al.
CNS Neuroscience & Therapeutics|January 5, 2011
Presynaptic dopamine in schizophreniaNobumi Miyake, Judy Thompson, Mette Skinbjerg, et al.
Psychiatry and Clinical Neurosciences|July 1, 2008
Successful treatment of delusional disorder with low-dose aripiprazoleSeiya Miyamoto, Nobumi Miyake, Shin Ogino, et al.
Psychiatry and Clinical Neurosciences|December 18, 2007
Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophreniaSeiya Miyamoto, Nobumi Miyake, Shin Ogino, et al.
Psychopharmacology|August 9, 2020
N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Nobumi Miyake, Makoto Okuya, et al.
Pageof 3